Today: 11 June 2026
Trump’s Maduro move in Venezuela tests markets: Chevron jumps, gold up ahead of Wall Street open
5 January 2026
2 mins read

Trump’s Maduro move in Venezuela tests markets: Chevron jumps, gold up ahead of Wall Street open

NEW YORK, January 5, 2026, 09:28 (EST) — Premarket

  • S&P 500 and Nasdaq futures were higher as energy shares rallied after President Donald Trump said U.S. forces captured Venezuela’s President Nicolas Maduro. 
  • Oil prices stayed rangebound near $61 a barrel, with traders citing ample supply and Trump’s insistence that a U.S. embargo on Venezuelan crude remains in place. 
  • Investors are watching Maduro’s New York court appearance and a busy U.S. data week that ends with Friday’s jobs report. 

U.S. stock futures edged higher before Monday’s open while oil and refinery shares jumped, as investors largely treated Washington’s weekend capture of Venezuelan President Nicolas Maduro as a contained shock rather than a broader risk-off event. 

The market’s early reaction matters because global equities entered 2026 near record highs, leaving little room for geopolitical surprises that could reprice risk quickly. The U.S. action in Venezuela is also the most direct intervention in Latin America since the 1989 invasion of Panama, a shift that investors say is hard to handicap. 

Investors are now weighing whether Trump’s warnings of possible further action — including threats directed at Colombia and Mexico — signal a broader willingness to use military force to achieve policy goals. Some strategists say markets have become desensitized, even as the episode revives questions about spillovers to other flashpoints, including Iran and Taiwan. 

Across asset classes, the moves were selective. Spot gold — a “safe-haven” asset investors often buy as a shelter during turmoil — was up about 2% at $4,418 an ounce, while Brent crude hovered near $61 a barrel.  Reuters

In equities, the tone remained steady into the open. At 8:41 a.m. ET, S&P 500 e-mini futures were up 0.23% and Nasdaq 100 e-minis were up 0.62%, while Dow e-minis were fractionally lower. 

Oil’s muted reaction sat at the center of investor debate. “The muted reaction (in oil prices) suggests that traders were looking beyond immediate geopolitical developments,” said David Morrison, senior market analyst at Trade Nation.  Reuters

Energy stocks moved sharply anyway, on the bet that Washington’s pressure campaign could eventually open access to Venezuela’s vast reserves even as Trump said the embargo on Venezuelan oil remained in place. Chevron was up about 6.5% in premarket trade, while refiners including Marathon Petroleum, Phillips 66, Valero and PBF Energy rose between 4% and 11%; oilfield services firms were also stronger. 

In credit markets, Venezuela’s defaulted government bonds and PDVSA debt rallied, with some prices up as much as 8.5 cents on the dollar, as investors positioned for a possible sovereign debt restructuring — the process of rewriting a country’s debts, often including “haircuts” that reduce what creditors get back. Analysts cautioned the process would likely be lengthy and complex given the size of Venezuela’s obligations and legal constraints.  Reuters

Policy uncertainty is still the overhang. Trump said he could order another strike if Venezuela does not cooperate with U.S. efforts to open up its oil industry and curb drug trafficking, and U.S. officials have told oil executives they would need to invest quickly if they want compensation for assets expropriated years ago, Reuters reported. 

But the downside scenario is clear: an escalation that disrupts regional stability, complicates sanctions policy, or delays investment in Venezuela’s aging energy infrastructure could reprice both oil and risk assets. Goldman Sachs has said any production recovery would likely be gradual and investment-heavy, with near-term price risks tied to how U.S. sanctions evolve. 

Later on Monday, investors will look for headlines from Maduro’s initial U.S. court appearance in New York, while macro traders turn to the ISM manufacturing report after the bell and Friday’s U.S. nonfarm payrolls data. Markets were pricing roughly 60 basis points of Federal Reserve rate cuts this year — about 0.60 percentage point — heading into the week. 

Stock Market Today

  • Can T-Mobile Sustain Its Strong Customer Growth Momentum?
    June 11, 2026, 11:20 AM EDT. T-Mobile US reported a 6% year-over-year increase in postpaid net additions for Q1 2026, adding 217,000 accounts to reach 34.4 million, driven by network quality, value offerings, and 5G adoption. Postpaid Average Revenue Per Account (ARPA) rose 3.9% to $151.93, aided by rate plan optimization and business services. The company also boosted broadband subscribers by over 500,000, benefiting from fixed wireless speeds and fiber partnerships. T-Mobile raised its 2026 guidance for postpaid net additions to 950,000-1.05 million and expects ARPA growth of 2.5-3%. Competitors AT&T and Verizon continue aggressive expansion in fiber and 5G broadband, adding significant new customers, intensifying industry competition. Despite growth, T-Mobile's shares have fallen 19.6% over the past year and trade at a higher price/earnings ratio than the industry average.

Latest articles

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

S&P 500, Nasdaq, Dow edge higher as chip names catch a bid

11 June 2026
Oracle plunged 12.5% after projecting fiscal 2027 capital spending far above Wall Street estimates and planning to raise nearly $40 billion in debt and equity, dragging software stocks lower even as chipmakers fueled a partial tech rebound following Wednesday’s AI-led selloff, Reuters reported.
Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks
Previous Story

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR
Next Story

NuScale Power stock jumps 16% as House sets ‘New Nuclear Era’ hearing — what’s next for SMR

Go toTop